Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

September 30, 2008

Study Completion Date

January 31, 2009

Conditions
Vernal Keratoconjunctivitis
Interventions
DRUG

Lactobacillus Rhamnosus GG

patients are treated with oral Lactobacillus Rhamnosus GG once daily for six months

DRUG

placebo (sugar)

Placebo will be administered to patients once daily for six months

Trial Locations (3)

Unknown

University of Genova, Genova

University of Padua, Padua

00155

University Campus Bio-Medico, Rome

All Listed Sponsors
collaborator

University of Genova

OTHER

collaborator

University of Padova

OTHER

lead

Campus Bio-Medico University

OTHER

NCT00445120 - Lactobacillus Rhamnosus GG Oral Treatment Efficacy on Vernal Keratoconjunctivitis Treatment | Biotech Hunter | Biotech Hunter